![Michael Chiu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Chiu
Vorstandsvorsitzender bei Kytopen Corp.
Aktive Positionen von Michael Chiu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Kytopen Corp.
![]() Kytopen Corp. Miscellaneous Commercial ServicesCommercial Services Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA. | Vorstandsvorsitzender | 07.08.2023 | - |
Karriereverlauf von Michael Chiu
Ehemalige bekannte Positionen von Michael Chiu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Erbi Biosystems, Inc.
![]() Erbi Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Erbi Biosystems, Inc. builds systems to automate the study of microorganisms for basic research. The company is headquartered In Woburn, MA. | Direktor/Vorstandsmitglied | 01.09.2018 | - |
Vorstandsvorsitzender | 01.09.2018 | - | |
Präsident | 01.09.2018 | - |
Ausbildung von Michael Chiu
University of Minnesota | Undergraduate Degree |
Massachusetts Institute of Technology AgeLab | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chief Executive Officer | 2 |
Director/Board Member | 1 |
President | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Erbi Biosystems, Inc.
![]() Erbi Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Erbi Biosystems, Inc. builds systems to automate the study of microorganisms for basic research. The company is headquartered In Woburn, MA. | Health Technology |
Kytopen Corp.
![]() Kytopen Corp. Miscellaneous Commercial ServicesCommercial Services Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA. | Commercial Services |
- Börse
- Insiders
- Michael Chiu
- Erfahrung